BPC-157

BPC-157 (Body Protection Compound-157) is being investigated for several clinical applications, though the evidence base remains limited and primarily consists of preclinical studies with minimal human clinical trial data.

Current Research Areas

Ischemia-Reperfusion Injury: Recent research has examined BPC-157's protective effects in lower extremity ischemia-reperfusion injury models in rats, suggesting potential applications in vascular and tissue protection scenarios.

Vascular Function: Studies have investigated BPC-157's effects on vascular function, including research on endothelium-dependent nitric oxide-mediated vasorelaxant effects in human internal mammary artery tissue.

Tissue Protection and Repair: BPC-157 is being studied for its cytoprotective properties, with research examining its effects in various tissue injury models. One ongoing Phase 2 clinical trial (NCT07437547) is investigating BPC-157 for acute hamstring muscle strain repair.

Endocrine Applications: The compound has been explored in the context of thyroid health and broader endocrine modulation, though specific clinical applications in this area remain investigational.

Clinical Trial Status

The clinical evidence for BPC-157 is extremely limited. Only two clinical trials are documented:

• A Phase 1 safety and pharmacokinetics trial (NCT02637284) with unknown status
• An active Phase 2 trial examining BPC-157 for hamstring muscle strain repair

Regulatory and Safety Considerations

BPC-157 has been identified as a doping agent subject to analytical detection methods, indicating regulatory oversight in sports applications. The compound faces significant biopharmaceutical challenges, formulation difficulties, and translational development barriers that limit its clinical advancement.

Evidence Limitations

Important Note: The clinical evidence for BPC-157 remains predominantly preclinical, with very limited human clinical trial data. Most research consists of animal studies and in vitro investigations. The safety profile, optimal dosing, and clinical efficacy in humans have not been adequately established through rigorous clinical trials.

This information is for educational purposes only and should not be considered medical advice. Consult with qualified healthcare professionals regarding any medical treatments.